EdgarLookup

SOLITRON DEVICES INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that SOLITRON DEVICES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
6.4%
Profit Margin
Net income ÷ revenue
3.3%
Return on Assets
Net income ÷ assets
0.37x
Debt-to-Equity
Total liabilities ÷ equity
+99.1%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2024 Feb 29, 2024 $12.76M Jul 12, 2024
FY2024 Feb 28, 2023 $6.41M Jul 12, 2024
FY2023 Feb 28, 2022 $12.28M Jun 23, 2023
FY2022 Feb 28, 2021 $10.53M Jul 14, 2022
FY2021 Feb 29, 2020 $9.24M Jun 21, 2021
FY2020 Feb 28, 2019 $9.38M Feb 22, 2021
FY2015 Feb 29, 2016 $8.40M Jun 15, 2016
FY2015 Feb 28, 2015 $9.76M Jun 15, 2016
FY2014 Feb 28, 2014 $8.65M May 29, 2015
FY2013 Feb 28, 2013 $8.42M May 27, 2014

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2015 Feb 29, 2016 $8.40M Jun 15, 2016
FY2015 Feb 28, 2015 $9.76M Jun 15, 2016
FY2014 Feb 28, 2014 $8.65M May 29, 2015
FY2013 Feb 28, 2013 $8.42M May 27, 2014
FY2012 Feb 29, 2012 $8.30M May 15, 2013
FY2011 Feb 28, 2011 $8.93M May 29, 2012

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Feb 28, 2025 $3.99M May 23, 2025
FY2025 Feb 29, 2024 $3.81M May 23, 2025
FY2024 Feb 28, 2023 $1.40M Jul 12, 2024
FY2023 Feb 28, 2022 $4.80M Jun 23, 2023
FY2022 Feb 28, 2021 $3.28M Jul 14, 2022
FY2021 Feb 29, 2020 $1.48M Jun 21, 2021
FY2020 Feb 28, 2019 $1.39M Feb 22, 2021
FY2015 Feb 29, 2016 $1.77M Jun 15, 2016
FY2015 Feb 28, 2015 $2.53M Jun 15, 2016
FY2014 Feb 28, 2014 $2.26M May 29, 2015

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Feb 28, 2025 $815.0K May 23, 2025
FY2025 Feb 29, 2024 $5.80M May 23, 2025
FY2024 Feb 28, 2023 $826.0K Jul 12, 2024
FY2023 Feb 28, 2022 $3.51M Jun 23, 2023
FY2022 Feb 28, 2021 $1.38M Jul 14, 2022
FY2021 Feb 29, 2020 ($606.0K) Jun 21, 2021
FY2020 Feb 28, 2019 ($1.44M) Feb 22, 2021
FY2015 Feb 29, 2016 ($165.0K) Jun 15, 2016
FY2015 Feb 28, 2015 $927.0K Jun 15, 2016
FY2014 Feb 28, 2014 $896.0K May 29, 2015

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Feb 28, 2025 $998.0K May 23, 2025
FY2025 Feb 29, 2024 $934.0K May 23, 2025
FY2024 Feb 28, 2023 ($651.0K) Jul 12, 2024
FY2023 Feb 28, 2022 $2.29M Jun 23, 2023
FY2022 Feb 28, 2021 $1.17M Jul 14, 2022
FY2021 Feb 29, 2020 ($629.0K) Jun 21, 2021
FY2020 Feb 28, 2019 ($1.35M) Feb 22, 2021
FY2015 Feb 29, 2016 ($195.0K) Jun 15, 2016
FY2015 Feb 28, 2015 $922.0K Jun 15, 2016
FY2014 Feb 28, 2014 $718.0K May 29, 2015

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Feb 28, 2025 $2.99M May 23, 2025
FY2025 Feb 29, 2024 $2.87M May 23, 2025
FY2024 Feb 28, 2023 $2.05M Jul 12, 2024
FY2023 Feb 28, 2022 $2.51M Jun 23, 2023
FY2022 Feb 28, 2021 $2.11M Jul 14, 2022
FY2021 Feb 29, 2020 $2.10M Jun 21, 2021
FY2020 Feb 28, 2019 $2.74M Feb 22, 2021
FY2015 Feb 29, 2016 $1.97M Jun 15, 2016
FY2015 Feb 28, 2015 $1.61M Jun 15, 2016
FY2014 Feb 28, 2014 $1.54M May 29, 2015

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Feb 28, 2025 $2.40M May 23, 2025
FY2025 Feb 29, 2024 $1.92M May 23, 2025
FY2024 Feb 28, 2023 $962.0K Jul 12, 2024
FY2023 Feb 28, 2022 $3.33M Jun 23, 2023
FY2022 Feb 28, 2021 $1.67M Jul 14, 2022
FY2021 Feb 29, 2020 $1.12M Jun 21, 2021
FY2020 Feb 28, 2019 ($1.87M) Feb 22, 2021
FY2015 Feb 29, 2016 $610.0K Jun 15, 2016
FY2015 Feb 28, 2015 $1.13M Jun 15, 2016
FY2014 Feb 28, 2014 $619.0K May 29, 2015

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Feb 28, 2025 $1.84M May 23, 2025
FY2025 Feb 29, 2024 $355.0K May 23, 2025
FY2024 Feb 28, 2023 $2.19M Jul 12, 2024
FY2023 Feb 28, 2022 $4.89M Jun 23, 2023
FY2022 Feb 28, 2021 $75.0K Jul 14, 2022
FY2021 Feb 29, 2020 $108.0K Jun 21, 2021
FY2020 Feb 28, 2019 $142.0K Feb 22, 2021
FY2015 Feb 29, 2016 $186.0K Jun 15, 2016
FY2015 Feb 28, 2015 $123.0K Jun 15, 2016
FY2014 Feb 28, 2014 $204.0K May 29, 2015

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Feb 28, 2025 $24.44M May 23, 2025
FY2025 Feb 29, 2024 $24.74M May 23, 2025
FY2024 Feb 28, 2023 $15.10M Jul 12, 2024
FY2023 Feb 28, 2022 $14.36M Jun 23, 2023
FY2022 Feb 28, 2021 $9.09M Jul 14, 2022
FY2021 Feb 29, 2020 $7.04M Jun 21, 2021
FY2020 Feb 28, 2019 $6.98M Feb 22, 2021
FY2015 Feb 29, 2016 $12.20M Jun 15, 2016
FY2015 Feb 28, 2015 $13.60M Jun 15, 2016
FY2014 Feb 28, 2014 $12.71M May 29, 2015

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Feb 28, 2025 $6.55M May 23, 2025
FY2025 Feb 29, 2024 $7.67M May 23, 2025
FY2024 Feb 28, 2023 $3.84M Jul 12, 2024
FY2023 Feb 28, 2022 $3.92M Jun 23, 2023
FY2022 Feb 28, 2021 $2.16M Jul 14, 2022
FY2021 Feb 29, 2020 $1.55M Jun 21, 2021
FY2020 Feb 28, 2019 $1.08M Feb 22, 2021
FY2015 Feb 29, 2016 $689.0K Jun 15, 2016
FY2015 Feb 28, 2015 $1.08M Jun 15, 2016
FY2014 Feb 28, 2014 $1.01M May 29, 2015

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Feb 28, 2025 $17.88M May 23, 2025
FY2025 Feb 29, 2024 $17.07M May 23, 2025
FY2025 Feb 28, 2023 $11.27M May 23, 2025
FY2024 Feb 28, 2022 $10.44M Jul 12, 2024
FY2023 Feb 28, 2021 $6.93M Jun 23, 2023
FY2022 Feb 29, 2020 $5.48M Jul 14, 2022
FY2020 Feb 28, 2019 $5.90M Feb 22, 2021
FY2015 Feb 29, 2016 $11.51M Jun 15, 2016
FY2015 Feb 28, 2015 $12.52M Jun 15, 2016
FY2014 Feb 28, 2014 $11.69M May 29, 2015

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Feb 28, 2025 $17.44M May 23, 2025
FY2025 Feb 29, 2024 $16.63M May 23, 2025
FY2024 Feb 28, 2023 $10.82M Jul 12, 2024
FY2023 Feb 28, 2022 $10.00M Jun 23, 2023
FY2022 Feb 28, 2021 $6.49M Jul 14, 2022
FY2021 Feb 29, 2020 $5.11M Jun 21, 2021
FY2020 Feb 28, 2019 $5.81M Feb 22, 2021
FY2015 Feb 29, 2016 $9.27M Jun 15, 2016
FY2015 Feb 28, 2015 $10.01M Jun 15, 2016
FY2014 Feb 28, 2014 $9.19M May 29, 2015

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Feb 28, 2025 $4.10M May 23, 2025
FY2025 Feb 29, 2024 $2.22M May 23, 2025
FY2023 Feb 28, 2023 $1.45M Jun 23, 2023
FY2023 Feb 28, 2022 $4.09M Jun 23, 2023
FY2022 Feb 28, 2021 $3.79M Jul 14, 2022
FY2022 Feb 29, 2020 $1.33M Jul 14, 2022
FY2021 Feb 28, 2019 $394.0K Jun 21, 2021
FY2020 Feb 28, 2018 $2.22M Feb 22, 2021
FY2015 Feb 29, 2016 $634.0K Jun 15, 2016
FY2015 Feb 28, 2015 $820.0K Jun 15, 2016

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Feb 28, 2025 $3.92M May 23, 2025
FY2025 Feb 29, 2024 $2.65M May 23, 2025

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Feb 28, 2025 0 May 23, 2025
FY2025 Feb 29, 2024 2 May 23, 2025
FY2015 Feb 29, 2016 0 Jun 15, 2016
FY2015 Feb 28, 2015 0 Jun 15, 2016
FY2014 Feb 28, 2014 0 May 29, 2015
FY2013 Feb 28, 2013 0 May 27, 2014
FY2012 Feb 29, 2012 0 May 15, 2013
FY2011 Feb 28, 2011 0 May 29, 2012

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2015 Feb 29, 2016 0 Jun 15, 2016
FY2015 Feb 28, 2015 0 Jun 15, 2016
FY2014 Feb 28, 2014 0 May 29, 2015
FY2013 Feb 28, 2013 0 May 27, 2014
FY2012 Feb 29, 2012 0 May 15, 2013
FY2011 Feb 28, 2011 0 May 29, 2012

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Feb 28, 2025 2.08M May 23, 2025
FY2025 Feb 29, 2024 2.08M May 23, 2025
FY2024 Feb 28, 2023 2.08M Jul 12, 2024
FY2023 Feb 28, 2022 2.08M Jun 23, 2023
FY2022 Feb 28, 2021 2.08M Jul 14, 2022
FY2021 Feb 29, 2020 2.06M Jun 21, 2021
FY2020 Feb 28, 2019 1.90M Feb 22, 2021
FY2015 Feb 29, 2016 2.23M Jun 15, 2016
FY2015 Feb 28, 2015 2.19M Jun 15, 2016
FY2014 Feb 28, 2014 2.18M May 29, 2015